OrthoPediatrics Corp. (NASDAQ:KIDS) Receives Average Rating of “Moderate Buy” from Analysts

Shares of OrthoPediatrics Corp. (NASDAQ:KIDS) have earned an average recommendation of “Moderate Buy” from the eleven research firms that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation, eight have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $24.6667.

Several research firms have recently issued reports on KIDS. BTIG Research lifted their price objective on shares of OrthoPediatrics from $23.00 to $24.00 and gave the stock a “buy” rating in a research report on Friday, February 27th. Needham & Company LLC raised their price target on OrthoPediatrics from $26.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, February 27th. TD Cowen raised OrthoPediatrics to a “strong-buy” rating in a report on Tuesday, January 27th. Canaccord Genuity Group started coverage on OrthoPediatrics in a research report on Wednesday, December 10th. They set a “buy” rating and a $24.00 price objective for the company. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of OrthoPediatrics in a report on Thursday, January 22nd.

Insider Transactions at OrthoPediatrics

In other OrthoPediatrics news, General Counsel Daniel J. Gerritzen sold 8,614 shares of the firm’s stock in a transaction that occurred on Monday, March 16th. The shares were sold at an average price of $17.25, for a total transaction of $148,591.50. Following the sale, the general counsel owned 149,533 shares of the company’s stock, valued at approximately $2,579,444.25. This trade represents a 5.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Gregory A. Odle sold 8,433 shares of the business’s stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $17.25, for a total transaction of $145,469.25. Following the sale, the insider owned 187,735 shares of the company’s stock, valued at $3,238,428.75. This represents a 4.30% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 58,171 shares of company stock valued at $1,003,450 over the last three months. 32.70% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Russell Investments Group Ltd. raised its stake in OrthoPediatrics by 433.1% during the 3rd quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock worth $26,000 after acquiring an additional 1,139 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its stake in OrthoPediatrics by 5,226.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company’s stock valued at $46,000 after acquiring an additional 2,561 shares in the last quarter. Caption Management LLC purchased a new position in shares of OrthoPediatrics during the third quarter worth about $54,000. BNP Paribas Financial Markets grew its holdings in shares of OrthoPediatrics by 60.2% during the third quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock worth $61,000 after purchasing an additional 1,235 shares during the last quarter. Finally, State of Wyoming increased its position in shares of OrthoPediatrics by 189.7% during the fourth quarter. State of Wyoming now owns 6,822 shares of the company’s stock worth $121,000 after purchasing an additional 4,467 shares in the last quarter. 69.05% of the stock is owned by hedge funds and other institutional investors.

OrthoPediatrics Stock Down 5.1%

Shares of NASDAQ:KIDS opened at $15.52 on Friday. OrthoPediatrics has a fifty-two week low of $15.28 and a fifty-two week high of $26.40. The firm’s 50 day moving average price is $17.31 and its 200 day moving average price is $17.70. The company has a quick ratio of 2.65, a current ratio of 5.55 and a debt-to-equity ratio of 0.28. The stock has a market cap of $392.35 million, a price-to-earnings ratio of -9.18 and a beta of 1.07.

OrthoPediatrics (NASDAQ:KIDS) last posted its quarterly earnings results on Thursday, February 26th. The company reported ($0.26) EPS for the quarter, topping the consensus estimate of ($0.37) by $0.11. OrthoPediatrics had a negative net margin of 16.77% and a negative return on equity of 6.70%. The company had revenue of $61.61 million during the quarter, compared to analysts’ expectations of $61.27 million. As a group, equities research analysts predict that OrthoPediatrics will post -0.93 earnings per share for the current fiscal year.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.